Business | I Buy Kegs for the Office. Do I Have to Buy Tampons, Too? Sections Skip to content Skip to site index work Friend Here’s the difference between ‘nice to have’ and ‘need to have’ products at work. Credit Credit Jens Mortensen for The New York Times Supported by ByMegan Greenwell Sept. 19, 2019, 11:52 a.m. ET Send questions about the office, money, careers and work-life balance to [email protected] . Include your name and location, even if you want them withheld. Letters may be edited. Tampons or Wine, the Eternal Dilemma I run a small but growing start-up and employ many young female employees. As is standard for the start-up world, we buy kitchen items for our staff, including snacks, beer and wine, paper towels and facial tissues. We have a board in the break area that we use to remind me what items we are getting low on. My employees keep putting feminine sanitary … [Read more...] about I Buy Kegs for the Office. Do I Have to Buy Tampons, Too?
Shares to buy singapore
Broadcom Inc. said that it agreed to buy Symantec Corp.'s division that serves business customers for $10.7 billion in cash, adding software designed to keep hackers out of corporate systems. The deal, which is expected to close in Broadcom's fiscal first quarter ending in January, comes less than a month after the two companies' discussions for a full merger fell apart over disagreements about the price. The transaction announced Thursday will refocus Symantec on its consumer-facing products, such as the LifeLock identity-protection brand and Norton antivirus software. The acquisition marks Broadcom's second big bet in software, after its $19 billion takeover of CA Technologies last year. Chief Executive Officer Hock Tan is spreading the reach of the company he built through acquisitions in the chip industry, and is now using a similar playbook to extract value from software assets that are struggling to grow. Symantec said the sale is expected to generate $8.2 billion after taxes, … [Read more...] about Broadcom to buy Symantec division
Jollibee to buy Coffee Bean chain for $350MLISTED Jollibee Foods Corp. announced on Wednesday it would buy the United States-based The Coffee Bean & Tea Leaf coffee chain for $350 million (P18 billion), making it the fastfood giant’s most significant and high-profile acquisition yet. In a disclosure, Jollibee said its Singapore-based subsidiary Jollibee Worldwide Pte. Ltd. would invest $100 million (P5 billion) in a new, still-unnamed holding firm, through which it would acquire Coffee Bean. The group will finance the amount through a bridge loan. The remaining $250 million would be advanced to the new company through the issuance of preferred shares in the next six to nine months.The $100-million investment is equivalent to an 80-percent ownership stake in the new firm. The remaining 20 percent would be subscribed by members of the family that owns Viet Thai International Joint Stock Co., a Jollibee Group partner in the Superfoods Group that runs Highlands Coffee and Pho24. … [Read more...] about Jollibee to buy Coffee Bean chain for $350M
(Reuters) - Drugmaker AbbVie Inc said on Tuesday it would buy Botox-maker Allergan Plc for about $63 billion, grabbing control of by far the biggest name in medical aesthetics to help reduce its reliance on blockbuster arthritis treatment Humira. FILE PHOTO: The Allergan logo is seen in this photo illustration in Singapore November 23, 2015. REUTERS/Thomas White/File Photo AbbVie has been under pressure to diversify its portfolio as Humira, the world’s best-selling drug, faces competition from cheaper versions in Europe. Allergan Chief Executive Officer Brent Saunders put together the current version of the company through a series of deals to roll up several pharmaceutical firms in 2014, and has run the company since then. He built his reputation as a dealmaker, but his company has struggled since Pfizer Inc walked away from a $160 billion deal to buy Allergan in 2016. Allergan’s shares have lost around half their value since then. Saunders has been under … [Read more...] about AbbVie to buy Botox-maker Allergan in $63 billion deal
Singapore state investor Temasek Holdings agreed to buy about 30 percent of Denmark's Haldor Topsoe A/S, the companies said, in a transaction that a source said values the engineering firm at around $1.5 billion. As part of the deal, Temasek [TEM.UL] will subscribe to secondary shares issued by the Topsoe family, which currently owns 100 percent of the company through Haldor Topsoe Holding A/S, said a person with direct knowledge of the deal. Haldor Topsoe, which confirmed the deal but did not disclose a price, said Temasek's global reach and connections in Asia and other emerging markets would bring value to the company. Haldor Topsoe is one of the world's leading industrial catalyst producers. It employs about 2,300 people and logged revenue of about $760 million in 2017. Temasek was shortlisted for exclusive talks and finalised a deal with Haldor Topsoe this week, beating global financial sponsors who were competing for the stake, said the person, who declined to be identified as … [Read more...] about Singapore’s Temasek to buy stake in Danish engineering firm